Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 15, 2026 09:00 ET | Source: China SXT Pharmaceuticals, Inc.

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research,...
January 15, 2026 08:15 ET | Source: Ocugen

Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2...
January 15, 2026 08:00 ET | Source: Incannex Healthcare

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Incannex earns global R&D recognition for advancing IHL-42X, a potential oral alternative for obstructive sleep apnea patients.
January 15, 2026 08:00 ET | Source: American Oncology Network

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research
January 15, 2026 08:00 ET | Source: R1 RCM Holdco Inc.

R1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves Accuracy

CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the launch of R1 Prior Authorization, a comprehensive solution...
January 15, 2026 08:00 ET | Source: Vaxart, Inc.

Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milk Norovirus-specific IgA in infant stool correlated with breast milk IgA,...
January 15, 2026 08:00 ET | Source: HMNC Holding GmbH

HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting

MUNICH, Germany, Jan. 15, 2026 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC”), a clinical-stage precision psychiatry biopharma company pioneering the development of personalized therapies powered...
January 15, 2026 07:45 ET | Source: Intermountain Health

Colorado, Montana, and Utah Among Nation’s Top States in RSV Protection for Babies Following Intermountain Health Awareness Effort

SALT LAKE CITY, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Colorado, Montana, and Utah are ranked in the nation’s top six states for protecting children against Respiratory Syncytial Virus (RSV) – an...
January 15, 2026 07:00 ET | Source: Abpro Corporation

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq: ABP), a clinical-stage biotechnology company developing next-generation antibody therapeutics for solid tumors,...
January 15, 2026 07:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...